The Renin-Angiotensin System Regulates Neurodegeneration in a Mouse Model of Optic Neuritis

Area of Science:

• Neuroimmunology
• Ophthalmology
• Cardiovascular Research

Background:

• The renin-angiotensin system (RAS), primarily mediated by angiotensin II (Ang II), is crucial for cardiovascular function.
• Emerging evidence implicates the RAS in the pathogenesis of autoimmune diseases.
• Optic neuritis, characterized by optic nerve inflammation and retinal ganglion cell loss, is closely associated with multiple sclerosis.

Purpose of the Study:

• To investigate the therapeutic potential of candesartan, an Ang II receptor antagonist, in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis.
• To elucidate the role of Ang II and its downstream signaling pathways in optic neuritis within the EAE model.

Main Methods:

• Oral administration of candesartan to mice with EAE.
• Assessment of demyelination in the optic nerve and spinal cord.
• Evaluation of retinal ganglion cell loss and visual function.
• In vitro studies using astrocytes to examine Ang II effects on Toll-like receptor (TLR)-4 expression and NF-κB activation.
• Analysis of monocyte chemoattractant protein 1 (MCP-1) production in response to Ang II and lipopolysaccharide (LPS).

Main Results:

• Ang II levels were elevated during the early phase of EAE.
• Candesartan treatment significantly reduced optic nerve and spinal cord demyelination in EAE mice.
• Retinal ganglion cell loss and visual impairment were attenuated by candesartan.
• In vitro, Ang II upregulated TLR-4 expression in astrocytes via the NF-κB pathway.
• Ang II enhanced LPS-induced MCP-1 production in astrocytes, an effect suppressed by candesartan or an NF-κB inhibitor.

Conclusions:

• The RAS, specifically Ang II, plays a significant role in the development of optic neuritis in EAE.
• The pathway involving RAS-NF-κB-TLR4 in glial cells represents a potential therapeutic target for neurodegeneration in neuroinflammatory conditions like multiple sclerosis.